My blog – Just another WordPress site

Our Social

Warrior Bio One LP

- Change the world with the power of biotech -

Book an apointment quickly?

Call us now!

We provide dedicated support for 24/7 for any of your question

+0962-58-58-258

About consulte

Company Overview

Warrior Bio One LP is an investment firm, focusing on biotechnology companies in the US. Our history started in 2018. Since then, we have believed the potential of biotech and biotech would change the world. Biotechnology is a branch of science that develops or creates products by utilizing biological systems, living creatures, or elements out of them. Biotechnology now encompasses a wide range of fields such as biochemistry, genetics, and molecular biology. Every year, new technologies and products are developed in fields such as medical, agriculture, and industrial biotechnology.

Office Address: 475 Northern Blvd Suite 36. Great Neck, NY 11021

General Partner: Joshua(Hua) Wang

Founded: 2018

Carmell Therapeutics

Investment Portfolio

Carmell Therapeutics, a Phase 2-stage biotechnology platform company developing allogeneic plasma-based biomaterials for bone and soft tissue healing indications, owns innovative technologies and management team.

Alpha Healthcare Acquisition Corp. III

ALPA, a special purpose acquisition company led by Mr. Rajiv Shukla, announced the execution of a definitive business combination agreement with Carmell Therapeutics Corporation.

Focus on Biotechnology in US

Investment Strategy

The global biotechnology market was estimated at USD 859.94 billion in 2022 and is expected to be worth around USD 1,683.52 billion by 2030 and poised to grow at a noteworthy CAGR of 8.7% from 2023 to 2030. Especially, the North America region dominated the global biotechnology market.

Biotechnology Market Size (Billion USD)

Biotechnology Market Share by Region in 2022 (Billion USD)

Our Value

Client First

As our world continues to face rapid and profound change, maintaining a precise understanding of market dynamics and the impact of economic volatility on the value of your business is crucial. Especially, there are so many updates happening due to the rapid advances in biotechnology. Today more than ever, the proven expertise and insights of dedicated valuation and biotechnology specialists can keep you on the path to opportunity and success.

Valuation Specialist

Our Valuation Team offers independent analysis and valuation of equity shares and IP when you are raising equity or debt financing, including modelling robust financial business plans based on insights gained thorough commercial due diligence. We can provide timely and impartial advice based on advanced data analytics, benchmarking, modelling and valuation concepts for deal pricing, capital-allocation strategies, synergy assessment and strategic-option assessment. We have a strong expertise in valuation for biotechnology companies, with deep knowledge of FDA approval process and variation in risk factors in each stage.